Page 129 - 80 guidelines for the treatment of malaria_opt

ANNEX 4. Antimalarials and malaria transmission

Mosquito control will be the most effective among the transmission blocking strategies
currently available to curtail the spread of drug resistance. Therapeutic strategies to reduce
the spread of drug resistant parasites will require using medicines in combination with
a partner medicine(s) having infectivity suppressive effects. These should be taken into
consideration in the formulation of national treatment policies. Suppression of malaria
infectivity should be considered an important activity component in the development
of antimalarial medicines.

a4.5 references
1. Hay SI et al. Annual Plasmodium falciparum entomological inoculation rates (EIR) across
Africa: literature survey, internet access and review. Transactions of the Royal Society of A4
Tropical Medicine and Hygiene, 2000. 94:113–127.
2. Lengeler C, Smith TA, Armstrong-Schellenberg J. Focus on the effect of bed nets on malaria
morbidity and mortality. Parasitology Today, 1997. 13:123–124.
3. Molineaux L. Malaria and mortality: some epidemiological considerations. Annals of
Tropical Medicine and Parasitology, 1997, 91:811–825.
4. White NJ. The role of anti-malarial drugs in eliminating malaria. Malaria Journal, 2008,
7(Suppl 1):S8.
5. Bruce-Chwatt L. Chemotherapy of malaria, 2nd ed. Geneva, World Health Organization,
1981.
6. Hogh B. The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the
infectivity of malaria species to the mosquito vector. American Journal of Tropical Medicine
and Hygiene, 1998, 58:176–182.
7. Robert V et al. Gametocytemia and infectivity to mosquitoes of patients with uncomplicated
Plasmodium falciparum malaria attacks treated with chloroquine or sulfadoxine plus
pyrimethamine. American Journal of Tropical Medicine and Hygiene, 2000, 62:210–216.
8. von Seidlein L et al. Risk factors for gametocyte carriage in Gambian children. American
Journal of Tropical Medicine and Hygiene, 2001, 65:523–527.
9. von Seidlein L et al. A randomized controlled trial of artemether/benflumetol, a new
antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum
malaria in African children. American Journal of Tropical Medicine and Hygiene, 1998,
58:638–644.
10. Targett G et al. Artesunate reduces but does not prevent post treatment transmission
of Plasmodium falciparum to Anopheles gambiae. Journal of Infectious Diseases, 2001,
183:1254–1259.
11. Drakeley CJ et al. Addition of artesunate to chloroquine for treatment of Plasmodium
falciparum malaria in Gambian children causes a significant but short-lived reduction
in infectiousness for mosquitoes. Tropical Medicine and International Health, 2004,
9:53–61.
115